Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated
- PMID: 34142700
- DOI: 10.1093/ibd/izab131
Infliximab De-escalation in Patients With Crohn's Disease in Clinical Remission Is Safe and Well-tolerated
Keywords: Crohn’s disease; dose de-escalation; inflammatory bowel disease; infliximab.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
